IT1250672B - Formulazioni orali di ubidecarenone in soluzione acquosa - Google Patents
Formulazioni orali di ubidecarenone in soluzione acquosaInfo
- Publication number
- IT1250672B IT1250672B ITMI911919A ITMI911919A IT1250672B IT 1250672 B IT1250672 B IT 1250672B IT MI911919 A ITMI911919 A IT MI911919A IT MI911919 A ITMI911919 A IT MI911919A IT 1250672 B IT1250672 B IT 1250672B
- Authority
- IT
- Italy
- Prior art keywords
- ubidecarenone
- aqueous solution
- oral formulations
- active ingredient
- castor oil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Vengono descritte formulazioni farmaceutiche, in forma di soluzioni acquose ad uso orale, contenenti come principio attivo ubidecarenone, caratterizzate dal fatto che contengono come tensioattivo non ionico olio di ricino idrogenato polietossilato 40.
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI911919A IT1250672B (it) | 1991-07-11 | 1991-07-11 | Formulazioni orali di ubidecarenone in soluzione acquosa |
| EP92111140A EP0522433A1 (en) | 1991-07-11 | 1992-07-01 | Oral aqueous solutions containing ubidecarenone |
| FR9208096A FR2678836B1 (fr) | 1991-07-11 | 1992-07-01 | Formulations pour voie orale d'ubidecarenone sous la forme de solutions aqueuses. |
| CH2169/92A CH684629A5 (fr) | 1991-07-11 | 1992-07-09 | Formulations pour voie orale d'ubidécarénone sous la forme de solutions aqueuses. |
| KR1019920012250A KR930001903A (ko) | 1991-07-11 | 1992-07-09 | 유비데카레논 경구용 수용액 제제 |
| JP4204214A JPH05186340A (ja) | 1991-07-11 | 1992-07-09 | 水性溶液形態のユビキノン含有経口製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI911919A IT1250672B (it) | 1991-07-11 | 1991-07-11 | Formulazioni orali di ubidecarenone in soluzione acquosa |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI911919A0 ITMI911919A0 (it) | 1991-07-11 |
| ITMI911919A1 ITMI911919A1 (it) | 1993-01-11 |
| IT1250672B true IT1250672B (it) | 1995-04-21 |
Family
ID=11360324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI911919A IT1250672B (it) | 1991-07-11 | 1991-07-11 | Formulazioni orali di ubidecarenone in soluzione acquosa |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0522433A1 (it) |
| JP (1) | JPH05186340A (it) |
| KR (1) | KR930001903A (it) |
| CH (1) | CH684629A5 (it) |
| FR (1) | FR2678836B1 (it) |
| IT (1) | IT1250672B (it) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2051643B1 (es) * | 1992-10-13 | 1995-02-16 | Inverni Della Beffa Farma | Formulaciones orales de ubidecarenona en forma de soluciones acuosas. |
| ES2074395B1 (es) * | 1993-02-25 | 1996-03-01 | Lifepharma Srl | Composicion farmaceutica o dietetica de elevada actividad antioxidante en las patologias cardiovasculares y/o hepaticas. |
| IT1263840B (it) * | 1993-03-30 | 1996-09-04 | Giuseppe Furiosi | Formulazioni orali di ubidecarenone in forma di capsule |
| US6054261A (en) * | 1998-05-20 | 2000-04-25 | Q-Pharma, Inc. | Coenzyme Q10 compositions for organ protection during perfusion |
| JP3742602B2 (ja) * | 2001-05-09 | 2006-02-08 | 株式会社カネカ | 還元型補酵素qの安定な溶液 |
| WO2003002147A1 (en) * | 2001-06-28 | 2003-01-09 | Takeda Chemical Industries, Ltd. | Preventives/remedies for organ functional disorders and organ dysfunction |
| JP3549197B2 (ja) | 2001-08-10 | 2004-08-04 | 日清ファルマ株式会社 | ユビキノン含有製剤 |
| JP3822479B2 (ja) | 2001-10-10 | 2006-09-20 | 株式会社カネカ | 還元型補酵素q水溶液の安定化組成 |
| JP4970734B2 (ja) * | 2005-03-03 | 2012-07-11 | 株式会社コーセー | 透明水性組成物 |
| KR100859781B1 (ko) * | 2007-03-26 | 2008-09-24 | (주)미토콘 | 유비데카레논-함유 약학 조성물 |
| CN105168135A (zh) | 2010-03-12 | 2015-12-23 | 博格有限责任公司 | 辅酶Q10(CoQ10)的静脉内制剂及其使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1334961A (fr) * | 1961-03-06 | 1963-08-16 | Merck & Co Inc | Solutions aqueuses stables à base de benzoquinone substituée |
| JPS58113127A (ja) * | 1981-12-28 | 1983-07-05 | Ajinomoto Co Inc | ユビデカレノン含有水性液 |
| CH667387A5 (it) * | 1985-12-24 | 1988-10-14 | Seuref Ag | Formulazioni farmaceutiche acquose di ubichinone. |
| JP2643217B2 (ja) * | 1988-01-22 | 1997-08-20 | エーザイ株式会社 | 脂溶性物質水性液 |
-
1991
- 1991-07-11 IT ITMI911919A patent/IT1250672B/it active IP Right Grant
-
1992
- 1992-07-01 EP EP92111140A patent/EP0522433A1/en not_active Withdrawn
- 1992-07-01 FR FR9208096A patent/FR2678836B1/fr not_active Expired - Fee Related
- 1992-07-09 JP JP4204214A patent/JPH05186340A/ja active Pending
- 1992-07-09 KR KR1019920012250A patent/KR930001903A/ko not_active Withdrawn
- 1992-07-09 CH CH2169/92A patent/CH684629A5/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI911919A1 (it) | 1993-01-11 |
| EP0522433A1 (en) | 1993-01-13 |
| JPH05186340A (ja) | 1993-07-27 |
| KR930001903A (ko) | 1993-02-22 |
| FR2678836A1 (fr) | 1993-01-15 |
| FR2678836B1 (fr) | 1995-06-09 |
| ITMI911919A0 (it) | 1991-07-11 |
| CH684629A5 (fr) | 1994-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
| ITRM920361A0 (it) | Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. | |
| FI960032L (fi) | Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten | |
| ZA200000603B (en) | Use of stilbene derivatives substituted in position 3, as deodrorant active agents in cosmetic compositions. | |
| ATE321534T1 (de) | Verbesserte liposomale formulierung | |
| IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
| IT1250672B (it) | Formulazioni orali di ubidecarenone in soluzione acquosa | |
| DK1104289T3 (da) | Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister | |
| FI955403A0 (fi) | Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä | |
| ES2180319T3 (es) | Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos. | |
| IT1272149B (it) | Composizione farmeceutiche ad attivita' analgesica | |
| ATE107853T1 (de) | Orales, melatonin enthaltendes arzneimittel. | |
| MXPA03000606A (es) | Derivados de benzofurano y su uso como agentes antibacterianos. | |
| ATE201680T1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze | |
| ES2060293T3 (es) | Nueva sustancia antiulcerosa. | |
| DE59102620D1 (de) | Feste orale Applikationsformen, die als Wirkstoff Ifosfamid enthalten. | |
| DE69207777D1 (de) | Körperpflegemittel | |
| MXPA01011842A (es) | Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas. | |
| YU87501A (sh) | Farmaceutski kompleksi | |
| ES2059756T3 (es) | Composiciones farmaceuticas que contienen primicina. | |
| ES2092559T3 (es) | Formulacion farmaceutica que contiene penciclovir. | |
| HRP20000703B1 (hr) | Stabilni pripravci koji sadrže levosimendan i alginsku kiselinu | |
| DE69007956D1 (de) | Antischwundadditiv enthaltender Dentalwirkstoff. | |
| ES2087178T3 (es) | Disulfato de ws7622a, procedimiento para su preparacion y su uso. | |
| ES2051643A1 (es) | Formulaciones orales de ubidecarenona en forma de soluciones acuosas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970730 |